BioNTech CEO Ugur Sahin besuchte Israel: Diskussion möglicher Zusammenarbeit bei der Pandemievorsorge und der Entwicklung innovativer Medikamente
07 sept. 2022 02h00 HE
|
BioNTech SE
JERUSALEM, Israel, und MAINZ, Deutschland, 7. September 2022 — BioNTech SE (Nasdaq: BNTX, „BioNTech“) gab heute bekannt, dass Prof. Ugur Sahin, CEO und Mitbegründer von BioNTech, nach Israel gereist...
Global microRNA (miRNA) Market to Reach $485.3 Million by 2026
29 août 2022 04h23 HE
|
Research and Markets
Dublin, Aug. 29, 2022 (GLOBE NEWSWIRE) -- The "microRNA (miRNA) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global microRNA (miRNA) Market...
Pfizer und BioNTech geben Update zur Wirksamkeit ihres COVID-19-Impfstoffs bei Kindern von 6 Monaten bis 4 Jahren
23 août 2022 06h45 HE
|
BioNTech SE
Daten einer weiterführenden Analyse mit 34 Fällen, die mindestens sieben Tage nach Verabreichung der primären Impfserie bestehend aus drei Dosen auftraten, zeigen eine Impfstoffwirksamkeit von 73,2 %...
Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age
23 août 2022 06h45 HE
|
BioNTech SE
Updated analysis from 34 cases occurring at least seven days following a three-dose regimen showed 73.2% vaccine efficacy among children ages 6 months through 4 yearsThe vaccine efficacy remained...
Dyadic Reports Second Quarter 2022 Financial Results and Highlights Recent Company Developments
10 août 2022 16h00 HE
|
Dyadic International, Inc.
Submission of a Clinical Trial Application (CTA) with South African Health Products Regulatory Authority (SAHPRA) to initiate a Phase 1 study to support clinical safety of proteins produced from...
Global RNA Extraction and Purification Kits, Reagents and Instruments Markets Report 2022-2035: 700+ RNA Extraction and Purification kits and Over 180 RNA Extraction and Purification Instruments
03 août 2022 06h38 HE
|
Research and Markets
Dublin, Aug. 03, 2022 (GLOBE NEWSWIRE) -- The "RNA Extraction and Purification Kits, Reagents and Instruments Market By Type of Product, Application Area, End Users, and Key Geographical Regions:...
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
25 juin 2022 10h02 HE
|
BioNTech SE
Omicron-adapted monovalent candidate given as a fourth booster dose elicited a 13.5 and 19.6-fold increase in neutralizing geometric titers against Omicron BA.1 at 30 µg and 60 µg dose levels;...
BioNTech beginnt Bau der ersten Produktionsstätte für mRNA-basierte Impfstoffe in Afrika
23 juin 2022 06h00 HE
|
BioNTech SE
Spatenstich in Kigali, Ruanda, für BioNTechs erste modulare mRNA-Produktionsstätte in Afrika; Lieferung der ersten Containermodule für Ende 2022 geplantAuf Einladung von Paul Kagame, Präsident der...
BioNTech Starts Construction of First mRNA Vaccine Manufacturing Facility in Africa
23 juin 2022 06h00 HE
|
BioNTech SE
Breaking of Ground for BioNTech’s initial African modular mRNA manufacturing facility in Kigali, Rwanda; delivery of first container modules planned for end of 2022On invitation by H.E. President Paul...
Global RNA Therapeutics Market Analysis Report 2022: Future Growth Potential Driven by Co-Development Programs and Robust Clinical Trials for Diverse Disease Areas
20 juin 2022 08h03 HE
|
Research and Markets
Dublin, June 20, 2022 (GLOBE NEWSWIRE) -- The "Global RNA Therapeutics Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This research service provides an overview...